Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Matsui

Showing results (661-670 of 735) with videos related to

Pageof 74
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2005
Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancerY Ohe, S Negoro, K Matsui, et al.
Anticancer Research|February 19, 2002
Telomerase activity in endoscopically visible lung cancerT Hirashima, O Yoshitaka, T Nitta, et al.
Human Pathology|November 9, 2000
Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 casesK Matsui, A Tatsuguchi, J Valencia, et al.
Mutagenesis|November 1, 1996
Evaluation of the genotoxicity of stevioside and steviol using six in vitro and one in vivo mutagenicity assaysM Matsui, K Matsui, Y Kawasaki, et al.
Japanese Journal of Clinical Oncology|October 1, 1996
Dose-escalation study of oral etoposide and carboplatin in patients with advanced lung cancerS Atagi, K Furuse, M Kawahara, et al.
Archives of Disease in Childhood|September 22, 1999
High IL-18 (interferon-gamma inducing factor) concentration in a purine nucleoside phosphorylase deficient patientT Yamamoto, Y Moriwaki, K Matsui, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 1978
Microautoradiographic studies on the cellular localization of radiothalliumP Som, K Matsui, H L Atkins, et al.
Surgical Oncology Clinics of North America|May 14, 2023
Advances in Radiotherapy for Brain MetastasesJennifer K Matsui, Haley K Perlow, Rituraj Upadhyay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2009
Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104)K Takeda, S Negoro, T Tamura, et al.
European Journal of Nuclear Medicine|January 1, 1983
97Ru-transferrin uptake in tumor and abscessP Som, Z H Oster, K Matsui, et al.
Pageof 74

Showing results (661-670 of 735) with videos related to

Sort By:
Pageof 74
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2005
Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancerY Ohe, S Negoro, K Matsui, et al.
Anticancer Research|February 19, 2002
Telomerase activity in endoscopically visible lung cancerT Hirashima, O Yoshitaka, T Nitta, et al.
Human Pathology|November 9, 2000
Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 casesK Matsui, A Tatsuguchi, J Valencia, et al.
Mutagenesis|November 1, 1996
Evaluation of the genotoxicity of stevioside and steviol using six in vitro and one in vivo mutagenicity assaysM Matsui, K Matsui, Y Kawasaki, et al.
Japanese Journal of Clinical Oncology|October 1, 1996
Dose-escalation study of oral etoposide and carboplatin in patients with advanced lung cancerS Atagi, K Furuse, M Kawahara, et al.
Archives of Disease in Childhood|September 22, 1999
High IL-18 (interferon-gamma inducing factor) concentration in a purine nucleoside phosphorylase deficient patientT Yamamoto, Y Moriwaki, K Matsui, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 1978
Microautoradiographic studies on the cellular localization of radiothalliumP Som, K Matsui, H L Atkins, et al.
Surgical Oncology Clinics of North America|May 14, 2023
Advances in Radiotherapy for Brain MetastasesJennifer K Matsui, Haley K Perlow, Rituraj Upadhyay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2009
Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104)K Takeda, S Negoro, T Tamura, et al.
European Journal of Nuclear Medicine|January 1, 1983
97Ru-transferrin uptake in tumor and abscessP Som, Z H Oster, K Matsui, et al.
Pageof 74